EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Understanding hepcidin for iron management in pregnancy

Sarah Rosson iD, Sue Pavord

Transfusion Medicine · 2025

DOI: 10.1111/tme.13125 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Transfusion Medicine, 2025. Verfasst von Sarah Rosson und 1 weiteren Autor:innen. Beteiligte Einrichtung: SUWON (Surgery, Oncology and Womens), Department of Haematology, University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: Hepcidins, Anemia, Iron-Deficiency, Iron, Pregnancy Complications, Hematologic. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Iron deficiency anaemia (IDA) poses a significant health challenge during pregnancy, affecting up to 30% of pregnant women in the UK. It has been linked to poor health outcomes for the mother, foetus, and the infant. Despite its prevalence and impact, current diagnostic and therapeutic approaches are limited. Ensuring an adequate iron status in pregnancy requires prompt investigation and treatment whilst avoiding excessive iron supplementation and its associated side effects. Hepcidin, a key regulator of iron trafficking in the body, has emerged as a promising candidate for tailoring iron supplementation to individual needs and responsiveness. However, current research on hepcidin‐based approaches yields mixed findings, necessitating a comprehensive review to elucidate its potential utility in guiding iron therapy for pregnant women with IDA. This literature review seeks to synthesise existing evidence to explore the role of hepcidin in personalised iron supplementation for pregnant women with IDA and to identify avenues for future research to pave the way for improved management of IDA in pregnancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepcidinsAnemia, Iron-DeficiencyIronPregnancy Complications, HematologicHumansPregnancyFemaleDietary Supplements

Stichwörter der Autor:innen

anaemiahepcidiniron deficiencyiron deficiency anaemiairon therapypregnancy

Substanzen

HepcidinsIron

Autor:innen und Institutionen

  • SUWON (Surgery, Oncology and Womens), Department of Haematology, University of Oxford, Oxford, UK.

ORCID-Profile: Sarah Rosson

Zitieren

APA

Rosson, S., & Pavord, S. (2025). Understanding hepcidin for iron management in pregnancy. Transfusion Medicine. https://doi.org/10.1111/tme.13125

Vancouver

Rosson S, Pavord S. Understanding hepcidin for iron management in pregnancy. Transfusion Medicine. 2025. doi:10.1111/tme.13125

BibTeX
@article{Rosson2025,
  author = {Rosson, Sarah and Pavord, Sue},
  title = {Understanding hepcidin for iron management in pregnancy},
  journal = {Transfusion Medicine},
  year = {2025},
  doi = {10.1111/tme.13125}
}
Kostenlos starten →